Peter Lange
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Peter Lange has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Charlotte Suppli Ulrik
Department of Respiratory Medicine, Copenhagen University Hospital - Hvidovre, Hvidovre, Denmark
7 shared publications - Jørgen Vestbo
Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
5 shared publications Jacob Louis Marott
The Copenhagen City Heart Study, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark
4 shared publications- Anders Løkke
Department of Medicine, Little Belt Hospital, 7100 Vejle, Denmark
2 shared publications Børge Grønne Nordestgaard
The Copenhagen City Heart Study, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark
2 shared publicationsHenrik Harving
2 shared publications
Latest Publications
- 15 October 2020
- Vol. 67 (11)
Management of patients with chronic obstructive lung disease, Type 2 diabetes and both diseases in primary care in Denmark.
We studied the implementation of recommended yearly control visits, quality of care and characteristics and co-morbidities of patients with chronic obstructive lung disease (COPD), Type 2 diabetes mellitus (T2DM) and those with both conditions in a sample of Danish general practices. This was a retrospective audit of patient records from 2017 in 164 general practices in Denmark. Up to 15 patients were randomly selected in each practice for assessment of relevant parameters and quality of care, producing a total of 820 patients with COPD, 823 patients with T2DM and 709 patients with both COPD and T2DM. Formalised annual control visits were completed in 72% of the patients with T2DM and 48% of the patients with COPD. Approximately 13% of the patients were followed by a specialist. Patients with both diseases had the highest number of healthcare contacts but the lowest fulfilment of annual control visits. The standard of care was fair, although assessment of the disease characteristics of COPD was less complete in patients with both conditions. Cardiovascular diseases including heart failure were significantly more common in patients with both conditions (42%) than in those with COPD only (29%) or T2DM only (27%). In 2017, the implementation of annual control visits for COPD was less complete than for T2DM. Patients with both diseases had the highest prevalence of cardiovascular disease and use of health resources, suggesting that this group needs additional attention. The present study was sponsored by Boehringer Ingelheim Denmark. not relevant.
- 15 October 2020
- Vol. 67 (11)
Management of patients with chronic obstructive lung disease, Type 2 diabetes and both diseases in primary care in Denmark.
We studied the implementation of recommended yearly control visits, quality of care and characteristics and co-morbidities of patients with chronic obstructive lung disease (COPD), Type 2 diabetes mellitus (T2DM) and those with both conditions in a sample of Danish general practices. This was a retrospective audit of patient records from 2017 in 164 general practices in Denmark. Up to 15 patients were randomly selected in each practice for assessment of relevant parameters and quality of care, producing a total of 820 patients with COPD, 823 patients with T2DM and 709 patients with both COPD and T2DM. Formalised annual control visits were completed in 72% of the patients with T2DM and 48% of the patients with COPD. Approximately 13% of the patients were followed by a specialist. Patients with both diseases had the highest number of healthcare contacts but the lowest fulfilment of annual control visits. The standard of care was fair, although assessment of the disease characteristics of COPD was less complete in patients with both conditions. Cardiovascular diseases including heart failure were significantly more common in patients with both conditions (42%) than in those with COPD only (29%) or T2DM only (27%). In 2017, the implementation of annual control visits for COPD was less complete than for T2DM. Patients with both diseases had the highest prevalence of cardiovascular disease and use of health resources, suggesting that this group needs additional attention. The present study was sponsored by Boehringer Ingelheim Denmark. not relevant.
- 6 May 2019
- Vol. 181 (19)
[Fraction of exhaled nitric oxide as biomarker of asthmatic airway inflammation].
Fraction of exhaled nitric oxide (FeNO) is an easily available online biomarker, which correlates with the presence of type 2 inflammation in the airways. Measurements of FeNO together with clinical assessment and spirometry have the potential to improve diagnosis and management of patients with chronic airway symptoms. High values of FeNO in patients with relevant symptoms increase the probability of asthma and a favourable response to inhaled cortico-steroids, but low values can be seen in various subtypes of asthma and in asthmatic patients, who smoke.
- 6 May 2019
- Vol. 181 (19)
[Fraction of exhaled nitric oxide as biomarker of asthmatic airway inflammation].
Fraction of exhaled nitric oxide (FeNO) is an easily available online biomarker, which correlates with the presence of type 2 inflammation in the airways. Measurements of FeNO together with clinical assessment and spirometry have the potential to improve diagnosis and management of patients with chronic airway symptoms. High values of FeNO in patients with relevant symptoms increase the probability of asthma and a favourable response to inhaled cortico-steroids, but low values can be seen in various subtypes of asthma and in asthmatic patients, who smoke.
- 1 July 2015
- Published by Elsevier in Respiratory Medicine
- Vol. 109 (7) , 821-827
Lung function impairment increases with age of diagnosis in adult onset asthma
- 1 July 2015
- Published by Elsevier in Respiratory Medicine
- Vol. 109 (7) , 821-827
Lung function impairment increases with age of diagnosis in adult onset asthma
- 8 June 2015
- Vol. 177 (24) , 1146-50
[Obese asthma patients have poorer asthma control].
Current literature indicates that asthma is more prevalent among obese individuals. In addition, studies have shown that higher body mass index (BMI), particularly BMI ≥ 30 kg/m2, is associated with poorer asthma control and asthma-related quality of life. Furthermore, growing evidence suggests that obese patients with asthma respond less favourably to inhaled corticosteroids compared to non-obese patients. Moreover, longitudinal studies indicate that weight reduction improves asthma control. Therefore, preventing and treating obesity should be an integrated part of asthma management.
- 8 June 2015
- Vol. 177 (24) , 1146-50
[Obese asthma patients have poorer asthma control].
Current literature indicates that asthma is more prevalent among obese individuals. In addition, studies have shown that higher body mass index (BMI), particularly BMI ≥ 30 kg/m2, is associated with poorer asthma control and asthma-related quality of life. Furthermore, growing evidence suggests that obese patients with asthma respond less favourably to inhaled corticosteroids compared to non-obese patients. Moreover, longitudinal studies indicate that weight reduction improves asthma control. Therefore, preventing and treating obesity should be an integrated part of asthma management.
- 1 December 2014
- Vol. 176 (49)
[Obese asthma patients have poorer asthma control].
Current literature indicates that asthma is more prevalent among obese individuals. In addition, studies have shown that higher body mass index (BMI), particularly BMI ≥ 30 kg/m2, is associated with poorer asthma control and asthma-related quality of life. Furthermore, growing evidence suggests that obese patients with asthma respond less favourably to inhaled corticosteroids compared to non-obese patients. Moreover, longitudinal studies indicate that weight reduction improves asthma control. Therefore, preventing and treating obesity should be an integrated part of asthma management.
- 1 December 2014
- Vol. 176 (49)
[Obese asthma patients have poorer asthma control].
Current literature indicates that asthma is more prevalent among obese individuals. In addition, studies have shown that higher body mass index (BMI), particularly BMI ≥ 30 kg/m2, is associated with poorer asthma control and asthma-related quality of life. Furthermore, growing evidence suggests that obese patients with asthma respond less favourably to inhaled corticosteroids compared to non-obese patients. Moreover, longitudinal studies indicate that weight reduction improves asthma control. Therefore, preventing and treating obesity should be an integrated part of asthma management.
- 29 April 2013
- Vol. 175 (18) , 1247-50
[Early diagnosis of COPD is important and possible].
Chronic obstructive pulmonary disease (COPD) is substantially underdiagnosed and under treated. The present review paper discusses the possibilities of early diagnosis by means of spirometry in the setting of Danish general practice. It is concluded that case finding of undiagnosed COPD is feasible by applying opportunistic spirometry in patients with relevant exposures and relevant respiratory symptoms. The potential barriers of this approach and possible solutions are discussed.
- 29 April 2013
- Vol. 175 (18) , 1247-50
[Early diagnosis of COPD is important and possible].
Chronic obstructive pulmonary disease (COPD) is substantially underdiagnosed and under treated. The present review paper discusses the possibilities of early diagnosis by means of spirometry in the setting of Danish general practice. It is concluded that case finding of undiagnosed COPD is feasible by applying opportunistic spirometry in patients with relevant exposures and relevant respiratory symptoms. The potential barriers of this approach and possible solutions are discussed.
- 14 December 2012
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 27 (12) , 933-943
Combined effect of lung function level and decline increases morbidity and mortality risks
Lung function level and decline are each predictive of morbidity and mortality. Evaluation of the combined effect of these measurements may help further identify high-risk groups. Using Copenhagen City Heart Study longitudinal spirometry data (n = 10,457), 16–21 year risks of chronic obstructive pulmonary disease (COPD) morbidity, COPD or coronary heart disease mortality, and all-cause mortality were estimated from combined effects of level and decline in forced expiratory volume in one second (FEV1). Risks were evaluated using Cox proportional hazards models for individuals grouped by combinations of baseline predicted FEV1 and quartiles of slope. Hazard ratios (HR) and 95 % confidence intervals (CI) were estimated using stratified analysis by gender, smoking status, and baseline age (≤45 and >45). For COPD morbidity, quartiles of increasing FEV1 decline increased HRs (95 % CI) for individuals with FEV1 at or above the lower limit of normal (LLN) but below 100 % predicted, reaching 5.11 (2.58–10.13) for males, 11.63 (4.75–28.46) for females, and 3.09 (0.88–10.86) for never smokers in the quartile of steepest decline. Significant increasing trends were also observed for mortality and in individuals with a baseline age ≤45. Groups with ‘normal’ lung function (FEV1 at or above the LLN) but excessive declines (fourth quartile of FEV1 slope) had significantly increased mortality risks, including never smokers and individuals with a baseline age ≤45.
- 14 December 2012
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 27 (12) , 933-943
Combined effect of lung function level and decline increases morbidity and mortality risks
Lung function level and decline are each predictive of morbidity and mortality. Evaluation of the combined effect of these measurements may help further identify high-risk groups. Using Copenhagen City Heart Study longitudinal spirometry data (n = 10,457), 16–21 year risks of chronic obstructive pulmonary disease (COPD) morbidity, COPD or coronary heart disease mortality, and all-cause mortality were estimated from combined effects of level and decline in forced expiratory volume in one second (FEV1). Risks were evaluated using Cox proportional hazards models for individuals grouped by combinations of baseline predicted FEV1 and quartiles of slope. Hazard ratios (HR) and 95 % confidence intervals (CI) were estimated using stratified analysis by gender, smoking status, and baseline age (≤45 and >45). For COPD morbidity, quartiles of increasing FEV1 decline increased HRs (95 % CI) for individuals with FEV1 at or above the lower limit of normal (LLN) but below 100 % predicted, reaching 5.11 (2.58–10.13) for males, 11.63 (4.75–28.46) for females, and 3.09 (0.88–10.86) for never smokers in the quartile of steepest decline. Significant increasing trends were also observed for mortality and in individuals with a baseline age ≤45. Groups with ‘normal’ lung function (FEV1 at or above the LLN) but excessive declines (fourth quartile of FEV1 slope) had significantly increased mortality risks, including never smokers and individuals with a baseline age ≤45.
- 14 May 2012
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 7 (2) , 153-167
New Danish reference values for spirometry
Introduction: International recommendations state that reference values for lung function should derive from cross‐sectional studies of healthy nonsmokers and be renewed from time to time because of cohort effect and newer, more accurate, technical equipment. In 1986, the Danish Lung Society published reference values for spirometry based on 570 individuals aged 30–70 years.Objectives: To produce new reference values for lung function and to extend the existing values by including individuals between 20 and 30 years of age and older than 70 years of age.Methods: Two similar but independent studies was used: The 2001–2003 examination of the Copenhagen City Heart Study and the 2003–2010 examination of the Copenhagen General Population Study. Of a total of 69 822 individuals, we included 11 288 healthy never‐smoking white individuals to produce the reference values: 6307 women and 4981 men, 20 years of age or older with adequate lung function.Results: We used sex‐stratified multiple linear regression analysis to find prediction formulas for forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC) and FEV1/FVC adjusted for age and height. The cutoff value of normal lung function was defined as the fifth percentile (also named the 5% quantile) according to gender, age and height. The robustness of the data was tested and validated in several ways.Conclusion: Compared with the 1986 data, our 2001–2010 material contributes with a substantial number of individuals in the more extreme groups of age and height, and in general, our dataset shows that in most subgroups, the lung function level has improved during the last two decades.Please cite this paper as: Løkke A, Marott JL, Mortensen J, Nordestgaard BG, Dahl M and Lange P. New Danish reference values for spirometry. Clin Respir J 2013; 7: 153–167.
- 14 May 2012
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 7 (2) , 153-167
New Danish reference values for spirometry
Introduction: International recommendations state that reference values for lung function should derive from cross‐sectional studies of healthy nonsmokers and be renewed from time to time because of cohort effect and newer, more accurate, technical equipment. In 1986, the Danish Lung Society published reference values for spirometry based on 570 individuals aged 30–70 years.Objectives: To produce new reference values for lung function and to extend the existing values by including individuals between 20 and 30 years of age and older than 70 years of age.Methods: Two similar but independent studies was used: The 2001–2003 examination of the Copenhagen City Heart Study and the 2003–2010 examination of the Copenhagen General Population Study. Of a total of 69 822 individuals, we included 11 288 healthy never‐smoking white individuals to produce the reference values: 6307 women and 4981 men, 20 years of age or older with adequate lung function.Results: We used sex‐stratified multiple linear regression analysis to find prediction formulas for forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC) and FEV1/FVC adjusted for age and height. The cutoff value of normal lung function was defined as the fifth percentile (also named the 5% quantile) according to gender, age and height. The robustness of the data was tested and validated in several ways.Conclusion: Compared with the 1986 data, our 2001–2010 material contributes with a substantial number of individuals in the more extreme groups of age and height, and in general, our dataset shows that in most subgroups, the lung function level has improved during the last two decades.Please cite this paper as: Løkke A, Marott JL, Mortensen J, Nordestgaard BG, Dahl M and Lange P. New Danish reference values for spirometry. Clin Respir J 2013; 7: 153–167.
- 1 April 2012
- Vol. 59 (4) , A4396
Substantial need for early diagnosis, rehabilitation and treatment of chronic obstructive pulmonary disease.
Our goal was to estimate the number of individuals with chronic obstructive pulmonary disease (COPD) in the Capital Region of Denmark and the need of resources required to implement the regional management programme for COPD. We examined a total of 45,970 participants from the Copenhagen General Population Study (CGPS) using spirometry and a questionnaire. The prevalence of spirometrically defined COPD among individuals older than 40 years of age was 15%, corresponding to 120,000 citizens in the Region. The number of individuals with moderate COPD (forced expiratory volume in one second (FEV1): 50-80% of predicted value) was estimated to approx. 51,000 (6.4%), whereas at least 10,000 (1.3%) were expected to have severe or very severe COPD (FEV1 < 50% of predicted value). Our estimates indicate that more than 26,000 individuals with moderate, severe or very severe COPD in the Region are smokers and that more than 19,000 qualify for physical training. We estimated that approx. 4,000 individuals with severe COPD were not treated with any inhaled medication. The Capital Region of Denmark needs to allocate substantial resources into early detection, rehabilitation and medical treatment of individuals with COPD in order to comply with the intentions of the Region's own management programme for COPD. The present analyses were sponsored by a grant from the Danish Ministry of Health. The CGPS was supported by the Copenhagen County Foundation, the Danish Medical Research Council and the Boserup Foundation. not relevant.
- 1 April 2012
- Vol. 59 (4) , A4396
Substantial need for early diagnosis, rehabilitation and treatment of chronic obstructive pulmonary disease.
Our goal was to estimate the number of individuals with chronic obstructive pulmonary disease (COPD) in the Capital Region of Denmark and the need of resources required to implement the regional management programme for COPD. We examined a total of 45,970 participants from the Copenhagen General Population Study (CGPS) using spirometry and a questionnaire. The prevalence of spirometrically defined COPD among individuals older than 40 years of age was 15%, corresponding to 120,000 citizens in the Region. The number of individuals with moderate COPD (forced expiratory volume in one second (FEV1): 50-80% of predicted value) was estimated to approx. 51,000 (6.4%), whereas at least 10,000 (1.3%) were expected to have severe or very severe COPD (FEV1 < 50% of predicted value). Our estimates indicate that more than 26,000 individuals with moderate, severe or very severe COPD in the Region are smokers and that more than 19,000 qualify for physical training. We estimated that approx. 4,000 individuals with severe COPD were not treated with any inhaled medication. The Capital Region of Denmark needs to allocate substantial resources into early detection, rehabilitation and medical treatment of individuals with COPD in order to comply with the intentions of the Region's own management programme for COPD. The present analyses were sponsored by a grant from the Danish Ministry of Health. The CGPS was supported by the Copenhagen County Foundation, the Danish Medical Research Council and the Boserup Foundation. not relevant.
- Open Access
- 20 September 2011
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 5, 3
Epidemiological aspects of systemic inflammation in COPD
- 20 September 2011
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 5, 3
Open AccessEpidemiological aspects of systemic inflammation in COPD